vs
Side-by-side financial comparison of Laird Superfood, Inc. (LSF) and QT IMAGING HOLDINGS, INC. (QTI). Click either name above to swap in a different company.
Laird Superfood, Inc. is the larger business by last-quarter revenue ($13.3M vs $8.3M, roughly 1.6× QT IMAGING HOLDINGS, INC.). Laird Superfood, Inc. runs the higher net margin — -13.2% vs -16.8%, a 3.6% gap on every dollar of revenue. On growth, QT IMAGING HOLDINGS, INC. posted the faster year-over-year revenue change (877.2% vs 15.0%).
Laird Superfood, Inc. develops, manufactures and sells a portfolio of plant-based functional superfood products, including premium coffee creamers, hydration blends, nutritional supplements, and plant-powered snacks. It serves health-conscious consumers through direct-to-consumer e-commerce platforms and offline retail partners, mainly operating in the North American market with a focus on sustainably sourced clean ingredients.
QT Imaging Holdings, Inc. is a medical technology company that designs, manufactures and commercializes non-invasive medical imaging systems primarily for breast health diagnostics. It serves healthcare providers, clinics and medical institutions across key markets including North America, Europe and Asia-Pacific, focusing on improving the accuracy and accessibility of diagnostic imaging for patients.
LSF vs QTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $13.3M | $8.3M |
| Net Profit | $-1.8M | $-1.4M |
| Gross Margin | 34.1% | 38.0% |
| Operating Margin | -13.5% | -8.5% |
| Net Margin | -13.2% | -16.8% |
| Revenue YoY | 15.0% | 877.2% |
| Net Profit YoY | -341.4% | 60.2% |
| EPS (diluted) | — | $-1.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.3M | $8.3M | ||
| Q3 25 | $12.9M | $4.2M | ||
| Q2 25 | $12.0M | $3.7M | ||
| Q1 25 | $11.7M | $2.8M | ||
| Q4 24 | $11.6M | — | ||
| Q3 24 | $11.8M | — | ||
| Q2 24 | $10.0M | $1.7M | ||
| Q1 24 | $9.9M | $1.4M |
| Q4 25 | $-1.8M | $-1.4M | ||
| Q3 25 | $-975.1K | $-4.6M | ||
| Q2 25 | $-362.2K | $-4.0M | ||
| Q1 25 | $-156.2K | $-11.1M | ||
| Q4 24 | $-398.4K | — | ||
| Q3 24 | $-166.1K | — | ||
| Q2 24 | $-239.1K | $-1.2M | ||
| Q1 24 | $-1.0M | $-628.6K |
| Q4 25 | 34.1% | 38.0% | ||
| Q3 25 | 36.5% | 43.0% | ||
| Q2 25 | 39.9% | 49.9% | ||
| Q1 25 | 41.9% | 64.7% | ||
| Q4 24 | 38.6% | — | ||
| Q3 24 | 43.0% | — | ||
| Q2 24 | 41.8% | 51.0% | ||
| Q1 24 | 40.0% | 55.8% |
| Q4 25 | -13.5% | -8.5% | ||
| Q3 25 | -7.7% | -39.4% | ||
| Q2 25 | -3.3% | -28.5% | ||
| Q1 25 | -1.9% | -37.2% | ||
| Q4 24 | -4.1% | — | ||
| Q3 24 | -2.3% | — | ||
| Q2 24 | -3.4% | -129.5% | ||
| Q1 24 | -11.0% | -409.5% |
| Q4 25 | -13.2% | -16.8% | ||
| Q3 25 | -7.6% | -108.7% | ||
| Q2 25 | -3.0% | -109.3% | ||
| Q1 25 | -1.3% | -397.9% | ||
| Q4 24 | -3.4% | — | ||
| Q3 24 | -1.4% | — | ||
| Q2 24 | -2.4% | -72.9% | ||
| Q1 24 | -10.3% | -46.1% |
| Q4 25 | — | $-1.00 | ||
| Q3 25 | — | $-0.47 | ||
| Q2 25 | — | $-0.14 | ||
| Q1 25 | — | $-0.40 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-0.30 | ||
| Q1 24 | — | $-0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $5.1M | $10.4M |
| Total DebtLower is stronger | — | $10.1M |
| Stockholders' EquityBook value | $11.5M | $6.4M |
| Total Assets | $19.2M | $23.0M |
| Debt / EquityLower = less leverage | — | 1.57× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $5.1M | $10.4M | ||
| Q3 25 | $5.1M | — | ||
| Q2 25 | $3.9M | — | ||
| Q1 25 | $7.0M | — | ||
| Q4 24 | $8.3M | — | ||
| Q3 24 | $7.9M | — | ||
| Q2 24 | $7.6M | — | ||
| Q1 24 | $7.1M | — |
| Q4 25 | — | $10.1M | ||
| Q3 25 | — | $15.1M | ||
| Q2 25 | — | $10.1M | ||
| Q1 25 | — | $10.2M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $11.7M | ||
| Q1 24 | — | $11.7M |
| Q4 25 | $11.5M | $6.4M | ||
| Q3 25 | $12.8M | $-9.1M | ||
| Q2 25 | $13.4M | $-324.3K | ||
| Q1 25 | $13.3M | $-20.2M | ||
| Q4 24 | $13.2M | — | ||
| Q3 24 | $13.1M | — | ||
| Q2 24 | $12.6M | $-6.2M | ||
| Q1 24 | $12.7M | $-4.9M |
| Q4 25 | $19.2M | $23.0M | ||
| Q3 25 | $18.9M | $12.1M | ||
| Q2 25 | $20.4M | $11.6M | ||
| Q1 25 | $21.5M | $10.9M | ||
| Q4 24 | $19.3M | — | ||
| Q3 24 | $18.8M | — | ||
| Q2 24 | $18.0M | $10.8M | ||
| Q1 24 | $17.6M | $12.9M |
| Q4 25 | — | 1.57× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $68.4K | $-3.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $68.4K | $-3.1M | ||
| Q3 25 | $1.2M | $-878.8K | ||
| Q2 25 | $-2.8M | $-1.4M | ||
| Q1 25 | $-1.3M | $-3.5M | ||
| Q4 24 | $339.2K | — | ||
| Q3 24 | $305.8K | — | ||
| Q2 24 | $642.7K | $-979.6K | ||
| Q1 24 | $-422.3K | $-6.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
QTI
Segment breakdown not available.
